Research Project

Project Title:	A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Complement 3 Glomerulopathy
Project Type:	Clinical Trial, Enrolment terminated
Disease group(s):	Immune glomerulopathies
Project Summary:	The Primary Completion Date and Study Completion Date have been updated to reflect completion of the adolescent cohort, which has been added to the protocol. The study is designed as a multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in complement 3 glomerulopathy.
Lead principal investigator(s):	Ioannis Boletis, Athens
Co-investigator(s):	Smaragdi Marinaki, Athens Stathis Tsiakas, Athens
Project Period:	07/2021 - 07/2026
Sponsors:	Industry
Project web page:	https://www.novartis.com/clinicaltrials/study/nct04817618
ClinicalTrials.gov:	NCT04817618
EudraCT Nr.:	2023-509331-83-00